Health3 days ago
FDA Approves Jazz Pharma’s Modeyso for Rare Brain Tumor Treatment
The US Food and Drug Administration (FDA) has granted accelerated approval to Jazz Pharmaceuticals for its treatment Modeyso (dordaviprone). This therapy is designated for adults and...
